Suppr超能文献

基于靶向富集的全基因组测序进行通用型人乳头瘤病毒基因分型:检测方法重复性和检测限的评估。

Universal human papillomavirus typing by whole genome sequencing following target enrichment: evaluation of assay reproducibility and limit of detection.

机构信息

Division of High-Consequence Pathogens & Pathology, Centers for Disease Control and Prevention, 1600 Clifton Road, Atlanta, GA, 30329, USA.

出版信息

BMC Genomics. 2019 Mar 20;20(1):231. doi: 10.1186/s12864-019-5598-0.

Abstract

BACKGROUND

We recently described a method for unbiased detection of all known human papillomaviruses (HPV) types with the potential for the determination of their variant and integration from the resulting whole genome sequence data. Considering the complex workflow for target-enriched next generation sequencing (NGS), we focused on the reproducibility and limit of detection (LOD) of this new universal HPV typing assay in this study.

RESULTS

We evaluated the reproducibility and LOD for HPV genotyping based on our recently published method that used RNA-baits targeting whole genomes of 191 HPV types, Agilent SureSelect protocol for target enrichment and Illumina HiSeq 2500 for sequencing (eWGS, enriched whole genome sequencing). Two libraries, prepared from pooled plasmids representing 9 vaccine HPV types at varying input (1-625 copies/reaction), were sequenced twice giving four replicates for evaluating reproducibility and LOD. eWGS showed high correlation in the number of reads mapped to HPV reference genomes between the two flow-cell lanes within (R = 1) and between experiments (R = 0.99). The number of mapped reads was positively correlated to copy number (β = 13.9, p < 0.0001). The limit of blank (LOB) could be calculated based on mapped reads to HPV types not included in each sample. HPV genotyping was reproducible for all 9 types at 625 copies using multiple cut-off criteria but LOD was 25 copies based on number of reads above LOB even when multiple types were present. eWGS showed no bias for HPV genotyping under single or multiple infection (p = 0.16-0.99).

CONCLUSIONS

The universal eWGS method for HPV genotyping has sensitivity, competitive with widely used consensus PCR methods with reduced type competition, and with the potential for determination of variant and integration status. The protocol used in this study, using defined samples varying in complexity and copy number, analyzed in replicate and duplicate assays, is applicable to most WGS methods.

摘要

背景

我们最近描述了一种用于检测所有已知人类乳头瘤病毒(HPV)类型的无偏方法,该方法具有从所得全基因组序列数据中确定其变体和整合的潜力。考虑到靶向富集下一代测序(NGS)的复杂工作流程,我们在本研究中专注于这种新的通用 HPV 分型检测的重现性和检测限(LOD)。

结果

我们根据我们最近发表的方法评估了 HPV 基因分型的重现性和 LOD,该方法使用针对 191 种 HPV 类型的全基因组的 RNA 诱饵、Agilent SureSelect 方案进行靶向富集和 Illumina HiSeq 2500 进行测序(eWGS,富集全基因组测序)。两个文库是从代表 9 种疫苗 HPV 类型的混合质粒制备的,输入量为 1-625 个拷贝/反应,每个文库进行两次测序,共得到 4 个重复样本来评估重现性和 LOD。eWGS 在两个流动池槽内(R=1)和在实验之间(R=0.99)HPV 参考基因组映射读取的数量具有高度相关性。映射读取的数量与拷贝数呈正相关(β=13.9,p<0.0001)。可以根据 HPV 类型的映射读取计算空白限(LOB)。使用多个截止标准,在 625 个拷贝时,所有 9 种类型的 HPV 基因分型都是可重现的,但 LOD 为 25 个拷贝,即使存在多种类型,也高于 LOB 的读取数。eWGS 在单感染或多感染下对 HPV 基因分型没有偏倚(p=0.16-0.99)。

结论

用于 HPV 基因分型的通用 eWGS 方法具有敏感性,与广泛使用的共识 PCR 方法相当,具有降低的类型竞争,并且具有确定变体和整合状态的潜力。本研究中使用的方案使用复杂程度和拷贝数不同的定义样本,在重复和重复实验中进行分析,适用于大多数 WGS 方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00fb/6425667/868344bd605c/12864_2019_5598_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验